Who owns C4 THERAPEUTICS INC?
- Ticker: CCCC
- CUSIP Number: 12529r107
Tip: Access positions for across all investors
Analyze quarterly positions in C4 Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of C4 Therapeutics stock
Who bought or sold C4 THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 4.9M | $28M | 100% | Dec 2023 |
|
Daniel D. Thurber | 4.3M | $35M | -39% | Mar 2024 |
|
Commodore Capital | 3.8M | $22M | 100% | Dec 2023 |
|
Lynx1 Capital Management | 3.1M | $18M | 208% | Dec 2023 |
|
T. Rowe Price Associates | 2.6M | $15M | 17% | Dec 2023 |
|
Arrowpoint Asset Management | 2.1M | $12M | -10% | Dec 2023 |
|
Vanguard Group | 2.0M | $11M | 4% | Dec 2023 |
|
Point72 Asset Management | 2.0M | $11M | 12142% | Dec 2023 |
|
Soleus Capital Management | 1.8M | $10M | -32% | Dec 2023 |
|
Balyasny Asset Management | 1.7M | $9.6M | 100% | Dec 2023 |
|
Bank of America Corporation | 1.7M | $9.5M | 3594% | Dec 2023 |
|
Marshall Wace | 1.1M | $6.3M | 100% | Dec 2023 |
|
Millennium Management | 757k | $4.3M | -35% | Dec 2023 |
|
Citadel Advisors | 353k | $2.0M | -16% | Dec 2023 |
|
Cubist Systematic Strategies | 311k | $1.8M | 357% | Dec 2023 |
|
UBS Group | 278k | $1.6M | -13% | Dec 2023 |
|
Charles Schwab Investment Management | 253k | $1.4M | 2% | Dec 2023 |
|
D. E. Shaw & Co | 244k | $1.4M | -44% | Dec 2023 |
|
Jane Street | 199k | $1.1M | 100% | Dec 2023 |
|
Connor, Clark & Lunn Investment Management | 168k | $950k | 2% | Dec 2023 |
|
Man Group | 160k | $903k | 6% | Dec 2023 |
|
AQR Capital Management | 149k | $840k | -86% | Dec 2023 |
|
M^T Bank Corporation | 139k | $783k | -1% | Dec 2023 |
|
Citigroup | 136k | $765k | 134% | Dec 2023 |
|
Mariner Wealth Advisors | 128k | $723k | 1% | Dec 2023 |
|
Dimensional Fund Advisors | 116k | $653k | -37% | Dec 2023 |
|
Goldman Sachs Group | 114k | $641k | -48% | Dec 2023 |
|
Schonfeld Strategic Advisors | 102k | $578k | 100% | Dec 2023 |
|
Jacobs Levy Equity Management | 100k | $567k | -88% | Dec 2023 |
|
TD Asset Management | 94k | $533k | 100% | Dec 2023 |
|
Bank Of Montreal | 77k | $463k | 100% | Dec 2023 |
|
Harbor Capital Advisors | 76k | $428k | 7% | Dec 2023 |
|
Two Sigma Advisers | 73k | $411k | -90% | Dec 2023 |
|
Arete Wealth Advisors | 72k | $407k | 100% | Dec 2023 |
|
Bellevue Group | 62k | $350k | 100% | Dec 2023 |
|
683 Capital Management | 56k | $314k | 100% | Dec 2023 |
|
Simplex Trading | 49k | $402k | -48% | Mar 2024 |
|
GSA Capital Partners | 49k | $398k | 100% | Mar 2024 |
|
CornerCap Investment Counsel | 46k | $262k | -2% | Dec 2023 |
|
Squarepoint Ops | 46k | $260k | 100% | Dec 2023 |
|
Barclays | 44k | $247k | 0% | Dec 2023 |
|
Royce & Associates | 43k | $240k | 100% | Dec 2023 |
|
Mirae Asset Global Investments | 41k | $138k | 100% | Mar 2024 |
|
Commonwealth Equity Services | 39k | $319k | 139% | Mar 2024 |
|
Hsbc Holdings | 30k | $171k | -8% | Dec 2023 |
|
Algert Coldiron Investors | 28k | $158k | -46% | Dec 2023 |
|
Mirabella Financial Services | 18k | $104k | 100% | Dec 2023 |
|
Captrust Financial Advisors | 15k | $84k | 0% | Dec 2023 |
|
Principal Financial Group | 13k | $108k | -10% | Mar 2024 |
|
CI Private Wealth | 13k | $72k | 0% | Dec 2023 |
|
Lazard Asset Management | 12k | $69k | 100% | Dec 2023 |
|
Sherbrooke Park Advisers | 11k | $63k | 100% | Dec 2023 |
|
Shay Capital | 10k | $57k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 6.9k | $39k | -25% | Dec 2023 |
|
Headlands Technologies | 6.9k | $39k | 100% | Dec 2023 |
|
Point72 Asia | 3.9k | $22k | 100% | Dec 2023 |
|
Rhumbline Advisers | 1.8k | $10k | 0% | Dec 2023 |
|
Wells Fargo & Company | 1.3k | $7.4k | 290% | Dec 2023 |
|
Syntax Research | 1.0k | $5.7k | 100% | Dec 2023 |
|
Cutler | 800.00 | $6.0k | -95% | Mar 2024 |
|
Piscataqua Savings Bank | 600.00 | $4.9k | 0% | Mar 2024 |
|
Royal Bank of Canada | 543.00 | $3.0k | -91% | Dec 2023 |
|
Efficient Wealth Management | 331.00 | $3.0k | 0% | Mar 2024 |
|
Coston, McIsaac & Partners | 23.00 | $0 | 21% | Mar 2024 |
|
Who sold out of C4 Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Aquilo Capital Management | Sep 2023 | 2.0M | $3.7M |
Nantahala Capital Management | Sep 2023 | 1.0M | $1.9M |
Two Sigma Investments | Sep 2023 | 403k | $749k |
Nextech Invest | Sep 2023 | 376k | $699k |
Raymond James & Associates | Dec 2023 | 101k | $571k |
Russell Investments | Sep 2023 | 96k | $178k |
Ohio Pers | Sep 2023 | 71k | $132k |
State of Wisconsin Investment Board | Sep 2023 | 30k | $56k |
Bank of New York Mellon | Dec 2023 | 21k | $117k |
Tudor Investment Corporation | Sep 2023 | 15k | $28k |
SG Americas Securities | Sep 2023 | 12k | $22k |
FNY Investment Advisers | Dec 2023 | 8.8k | $49k |
Federated Investors | Sep 2023 | 3.1k | $5.8k |
Advisor Group Holdings | Sep 2023 | 1.0k | $1.9k |
EverSource Wealth Advisors | Sep 2023 | 448.00 | $833.011200 |